These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
564 related articles for article (PubMed ID: 26944863)
1. Preference for and efficacy of oral levonorgestrel for emergency contraception with concomitant placement of a levonorgestrel IUD: a prospective cohort study. Turok DK; Sanders JN; Thompson IS; Royer PA; Eggebroten J; Gawron LM Contraception; 2016 Jun; 93(6):526-32. PubMed ID: 26944863 [TBL] [Abstract][Full Text] [Related]
2. One-year continuation of copper or levonorgestrel intrauterine devices initiated at the time of emergency contraception. Sanders JN; Turok DK; Royer PA; Thompson IS; Gawron LM; Storck KE Contraception; 2017 Aug; 96(2):99-105. PubMed ID: 28596121 [TBL] [Abstract][Full Text] [Related]
3. Emergency contraception with a copper IUD or oral levonorgestrel: an observational study of 1-year pregnancy rates. Turok DK; Jacobson JC; Dermish AI; Simonsen SE; Gurtcheff S; McFadden M; Murphy PA Contraception; 2014 Mar; 89(3):222-8. PubMed ID: 24332433 [TBL] [Abstract][Full Text] [Related]
4. Unprotected intercourse in the 2 weeks prior to requesting emergency intrauterine contraception. Sanders JN; Howell L; Saltzman HM; Schwarz EB; Thompson IS; Turok DK Am J Obstet Gynecol; 2016 Nov; 215(5):592.e1-592.e5. PubMed ID: 27349294 [TBL] [Abstract][Full Text] [Related]
5. Levonorgestrel vs. Copper Intrauterine Devices for Emergency Contraception. Turok DK; Gero A; Simmons RG; Kaiser JE; Stoddard GJ; Sexsmith CD; Gawron LM; Sanders JN N Engl J Med; 2021 Jan; 384(4):335-344. PubMed ID: 33503342 [TBL] [Abstract][Full Text] [Related]
6. Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine system. Suvisaari J; Lähteenmäki P Contraception; 1996 Oct; 54(4):201-8. PubMed ID: 8922872 [TBL] [Abstract][Full Text] [Related]
7. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception. Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577 [TBL] [Abstract][Full Text] [Related]
8. Safety of levonorgestrel 52 mg intrauterine system compared to copper intrauterine device: a population-based cohort study. Bosco-Lévy P; Gouverneur A; Langlade C; Miremont G; Pariente A Contraception; 2019 Jun; 99(6):345-349. PubMed ID: 30871933 [TBL] [Abstract][Full Text] [Related]
9. Two years of intrauterine contraception with levonorgestrel and with copper: a randomized comparison of the TCu 380Ag and levonorgestrel 20 mcg/day devices. Sivin I; Stern J; Diaz J; Diaz MM; Faundes A; el Mahgoub S; Diaz S; Pavez M; Coutinho E; Mattos CE Contraception; 1987 Mar; 35(3):245-55. PubMed ID: 3111785 [TBL] [Abstract][Full Text] [Related]
10. Copper T380 intrauterine device for emergency contraception: highly effective at any time in the menstrual cycle. Turok DK; Godfrey EM; Wojdyla D; Dermish A; Torres L; Wu SC Hum Reprod; 2013 Oct; 28(10):2672-6. PubMed ID: 23945595 [TBL] [Abstract][Full Text] [Related]
11. A pilot study of the Copper T380A IUD and oral levonorgestrel for emergency contraception. Turok DK; Gurtcheff SE; Handley E; Simonsen SE; Sok C; Murphy P Contraception; 2010 Dec; 82(6):520-5. PubMed ID: 21074014 [TBL] [Abstract][Full Text] [Related]
12. Interventions for emergency contraception. Shen J; Che Y; Showell E; Chen K; Cheng L Cochrane Database Syst Rev; 2017 Aug; 8(8):CD001324. PubMed ID: 28766313 [TBL] [Abstract][Full Text] [Related]
13. Interventions for emergency contraception. Shen J; Che Y; Showell E; Chen K; Cheng L Cochrane Database Syst Rev; 2019 Jan; 1(1):CD001324. PubMed ID: 30661244 [TBL] [Abstract][Full Text] [Related]
14. Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices. Heinemann K; Reed S; Moehner S; Minh TD Contraception; 2015 Apr; 91(4):280-3. PubMed ID: 25601350 [TBL] [Abstract][Full Text] [Related]
15. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties. Luukkainen T; Toivonen J Contraception; 1995 Nov; 52(5):269-76. PubMed ID: 8585882 [TBL] [Abstract][Full Text] [Related]
16. HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial. Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium Lancet; 2019 Jul; 394(10195):303-313. PubMed ID: 31204114 [TBL] [Abstract][Full Text] [Related]
17. A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls. Bahamondes L; Brache V; Meirik O; Ali M; Habib N; Landoulsi S; Hum Reprod; 2015 Nov; 30(11):2527-38. PubMed ID: 26409014 [TBL] [Abstract][Full Text] [Related]
18. Choice of Emergency Contraceptive and Decision Making Regarding Subsequent Unintended Pregnancy. Royer PA; Turok DK; Sanders JN; Saltzman HM J Womens Health (Larchmt); 2016 Oct; 25(10):1038-1043. PubMed ID: 27032057 [TBL] [Abstract][Full Text] [Related]
19. Comparison of two cohorts of women who expulsed either a copper-intrauterine device or a levonorgestrel-releasing intrauterine system. Simonatto P; Bahamondes MV; Fernandes A; Silveira C; Bahamondes L J Obstet Gynaecol Res; 2016 May; 42(5):554-9. PubMed ID: 26817571 [TBL] [Abstract][Full Text] [Related]
20. Acceptability of randomization to levonorgestrel versus copper intrauterine device among women requesting IUD insertion for contraception. Achilles SL; Chen BA; Lee JK; Gariepy AM; Creinin MD Contraception; 2015 Dec; 92(6):572-4. PubMed ID: 26297203 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]